Search all medical codes

Adverse effect of antineoplastic and immunosuppressive drugs, sequela

ICD10CM code

Medical Policies and Guidelines for Adverse effect of antineoplastic and immunosuppressive drugs, sequela

Related policies from health plans

Varubi (rolapitant) (PG178)

Similar Codes


ICD10CM codes

T45.1X5S - Adverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.1X5 - Adverse effect of antineoplastic and immunosuppressive drugs
T45.1X6S - Underdosing of antineoplastic and immunosuppressive drugs, sequela
T45.1X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5A - Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X1S - Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela
T45.1X4S - Poisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela
T45.1X3S - Poisoning by antineoplastic and immunosuppressive drugs, assault, sequela
T45.8X5S - Adverse effect of other primarily systemic and hematological agents, sequela
T45.1X2S - Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela

HCPCS codes

J9999 - Not otherwise classified, antineoplastic drugs
J7599 - Immunosuppressive drug, not otherwise classified
G8927 - Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
S9359 - Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
J9000 - Injection, doxorubicin hydrochloride, 10 mg
J9055 - Injection, cetuximab, 10 mg
Q2050 - Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
J8700 - Temozolomide, oral, 5 mg
Q5102 - Injection, infliximab, biosimilar, 10 mg
D9610 - THERAPEUTIC PARENTERAL DRUG

CPT4 codes

96402 - Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
96401 - Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96406 - Chemotherapy administration; intralesional, more than 7 lesions
80193 - Leflunomide
96405 - Chemotherapy administration; intralesional, up to and including 7 lesions
4037F - Influenza immunization ordered or administered (COPD, PV, CKD, ESRD)(IBD)
96549 - Unlisted chemotherapy procedure
88239 - Tissue culture for neoplastic disorders; solid tumor
80230 - Infliximab
3775F - Adenoma(s) or other neoplasm detected during screening colonoscopy (SCADR)